Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes. Following our analysis of the options activities associated with Vertex Pharmaceuticals ...

A substantial insider activity was disclosed on August 26, as SCHWAB, Chief Financial Officer at Vertex (NASDAQ:VERX), reported the exercise of a large sell of company stock options. What Happened ...